Physician profile
Michael R Wallace
NPI 1295828416
$892.66
in general payments reported to CMS, 2019-2025
9 companies · $90.09 in 2025
The $90.09 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $55.99 · 2021: $57.22 · 2022: $62.12 · 2023: $208 · 2024: $271 · 2025: $90.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $478.82 | 2022-2025 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $88.48 | 2019 | |
| Organogenesis INC. | $82.52 | 2020-2023 | Puraply |
| Averitas Pharma INC. | $74.02 | 2023-2025 | Qutenza |
| Kci USA, INC. | $60.12 | 2019 | |
| Nevro Corp. | $50.29 | 2021-2024 | Senza |
| Mimedx Group, INC. | $21.48 | 2024 | |
| Stryker Corporation | $19.79 | 2021 | |
| Bioventus LLC | $17.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.